American Heart Journal Plus (Mar 2022)

Comparison of clinical symptoms and bioimpedance to pulmonary capillary wedge pressure in heart failure

  • Monica Polcz,
  • Jessica Huston,
  • Meghan Breed,
  • Marisa Case,
  • Philip Leisy,
  • Jeffrey Schmeckpeper,
  • Lexie Vaughn,
  • Jenna Helmer Sobey,
  • Colleen Brophy,
  • JoAnn Lindenfeld,
  • Kyle Hocking,
  • Bret Alvis

Journal volume & issue
Vol. 15
p. 100133

Abstract

Read online

Introduction: Clinical symptoms of heart failure commonly include fatigue, edema, and shortness of breath. Unfortunately, clinical monitoring has proven unreliable in predicting congestion and the need for hospitalization. Biosensing wearables have been developed as a potential adjunct to clinical signs and symptoms to detect congestion before it becomes severe thus preventing a heart failure hospitalization. Hypothesis: Clinical signs and symptoms of heart failure will correlate with thoracic bioimpedance measurements (ZOE®) and pulmonary capillary wedge pressure (PCWP). Methods: One hundred and fifty-five subjects undergoing right heart catheterization (RHC) were prospectively enrolled. A Zo value (ohms) was obtained, jugular venous pressure (JVP) was estimated, edema graded, and shortness of breath (SOB) assessed in all subjects. RHC was performed by a scheduled cardiologist per routine. One-way ANOVA was performed to assess the relationship between variables. A Pearson correlation coefficient was used to compare the Zo value and PCWP. Results: Neither estimated JVP (cmH2O) (p = 0.65, n = 110) nor edema scores (p = 0.12, n = 110) demonstrated a significant relationship to PCWP. The presence of subjective SOB also did not demonstrate a significant association with PCWP (p = 0.99, n = 110). There was no correlation between ZOE® and PCWP (r = −0.08, p = 0.56, n = 56). Conclusions: These findings support the idea that traditional measures for monitoring heart failure patients are limited.

Keywords